메뉴 건너뛰기




Volumn 18, Issue 17, 2010, Pages 6377-6388

Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2- chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist

Author keywords

Cannabinoid; Obesity; Rimonabant; Thiadiazole; Triazole

Indexed keywords

2 (4 ((1H 1,2,4 TRIAZOL 1 YL)METHYL) 5 (4 BROMOPHENYL) 1 (2 CHLOROPHENYL) 1H PYRAZOL 3 YL) 5 TERT BUTYL 1,3,4 THIADIAZOLE; 2 (4 ((1H 1,2,4 TRIAZOL 1 YL)METHYL) 5 (4 BROMOPHENYL) 1 (2,4 DICHLOROPHENYL) 1H PYRAZOL 3 YL) 5 TERT BUTYL 1,3,4 THIADIAZOLE; 2 (4 ((1H 1,2,4 TRIAZOL 1 YL)METHYL) 5 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENYL) 1H PYRAZOL 3 YL) 5 (1 (TRIFLUOROMETHYL) CYCLOBUTYL) 1,3,4 THIADIAZOLE; CANNABINOID 1 RECEPTOR ANTAGONIST; GCC 2680; RIMONABANT; TARANABANT; UNCLASSIFIED DRUG;

EID: 77955982624     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.07.013     Document Type: Article
Times cited : (12)

References (45)
  • 18
    • 77955982444 scopus 로고    scopus 로고
    • PCT Patent WO 2007/046550 A1
    • Moritani, Y. PCT Patent WO 2007/046550 A1, 2007.
    • (2007)
    • Moritani, Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.